Table of Content

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Allergy Immunotherapy Market

4. Market Overview
    4.1. Introduction
        4.1.1. Product Definition
        4.1.2. Industry Evolution / Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Allergy Immunotherapy Market Analysis and Forecast, 2017–2031
    4.5. Porter’s Five Force Analysis

5. Key Insights
    5.1. COVID-19 Pandemic Impact on Industry

6. Global Allergy Immunotherapy Market Analysis and Forecast, by Treatment
    6.1. Introduction & Definition
    6.2. Key Findings / Developments
    6.3. Market Value Forecast, by Treatment, 2017–2031
        6.3.1. Subcutaneous Immunotherapy (SCIT)
        6.3.2. Sublingual Immunotherapy (SLIT)
    6.4. Market Attractiveness Analysis, by Treatment

7. Global Allergy Immunotherapy Market Analysis and Forecast, by Allergy Type
    7.1. Introduction & Definition
    7.2. Key Findings / Developments
    7.3. Market Value Forecast, by Allergy Type, 2017–2031
        7.3.1. Allergic Rhinitis
        7.3.2. Asthma
        7.3.3. Food Allergy
        7.3.4. Venom Allergy
        7.3.5. Others
    7.4. Market Attractiveness Analysis, By Allergy Type

8. Global Allergy Immunotherapy Market Analysis and Forecast, by Distribution Channel
    8.1. Introduction & Definition
    8.2. Key Findings / Developments
    8.3. Market Value Forecast, by Distribution Channel, 2017–2031
        8.3.1. Hospital Pharmacies
        8.3.2. Retail Pharmacies & Drug Stores
        8.3.3. Online Pharmacies
    8.4. Market Attractiveness Analysis, By Distribution Channel

9. Global Allergy Immunotherapy Market Analysis and Forecast, by Region
    9.1. Key Findings
    9.2. Market Value Forecast, by Region
        9.2.1. North America
        9.2.2. Europe
        9.2.3. Asia Pacific
        9.2.4. Latin America
        9.2.5. Middle East & Africa
    9.3. Market Attractiveness Analysis, by Region

10. North America Allergy Immunotherapy Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Key Findings
    10.2. Market Value Forecast, by Treatment, 2017–2031
        10.2.1. Subcutaneous Immunotherapy (SCIT)
        10.2.2. Sublingual Immunotherapy (SLIT)
    10.3. Market Value Forecast, by Allergy Type, 2017–2031
        10.3.1. Allergic Rhinitis
        10.3.2. Asthma
        10.3.3. Food Allergy
        10.3.4. Venom Allergy
        10.3.5. Others
    10.4. Market Value Forecast, by Distribution Channel, 2017–2031
        10.4.1. Hospital Pharmacies
        10.4.2. Retail Pharmacies & Drug Stores
        10.4.3. Online Pharmacies
    10.5. Market Value Forecast, by Country, 2017–2031
        10.5.1. U.S.
        10.5.2. Canada
    10.6. Market Attractiveness Analysis
        10.6.1. By Treatment
        10.6.2. By Allergy Type
        10.6.3. By Distribution Channel
        10.6.4. By Country

11. Europe Allergy Immunotherapy Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Treatment, 2017–2031
        11.2.1. Subcutaneous Immunotherapy (SCIT)
        11.2.2. Sublingual Immunotherapy (SLIT)
    11.3. Market Value Forecast, by Allergy Type, 2017–2031
        11.3.1. Allergic Rhinitis
        11.3.2. Asthma
        11.3.3. Food Allergy
        11.3.4. Venom Allergy
        11.3.5. Others
    11.4. Market Value Forecast, by Distribution Channel, 2017–2031
        11.4.1. Hospital Pharmacies
        11.4.2. Retail Pharmacies & Drug Stores
        11.4.3. Online Pharmacies
    11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        11.5.1. Germany
        11.5.2. U.K.
        11.5.3. France
        11.5.4. Italy
        11.5.5. Spain
        11.5.6. Rest of Europe
    11.6. Market Attractiveness Analysis
        11.6.1. By Treatment
        11.6.2. By Allergy Type
        11.6.3. By Distribution Channel
        11.6.4. By Country/Sub-region

12. Asia Pacific Allergy Immunotherapy Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Treatment, 2017–2031
        12.2.1. Subcutaneous Immunotherapy (SCIT)
        12.2.2. Sublingual Immunotherapy (SLIT)
    12.3. Market Value Forecast, by Allergy Type, 2017–2031
        12.3.1. Allergic Rhinitis
        12.3.2. Asthma
        12.3.3. Food Allergy
        12.3.4. Venom Allergy
        12.3.5. Others
    12.4. Market Value Forecast, by Distribution Channel, 2017–2031
        12.4.1. Hospital Pharmacies
        12.4.2. Retail Pharmacies & Drug Stores
        12.4.3. Online Pharmacies
    12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        12.5.1. China
        12.5.2. India
        12.5.3. Japan
        12.5.4. Australia & New Zealand
        12.5.5. Rest of Asia Pacific
    12.6. Market Attractiveness Analysis
        12.6.1. By Treatment
        12.6.2. By Allergy Type
        12.6.3. By Distribution Channel
        12.6.4. By Country/Sub-region
13. Latin America Allergy Immunotherapy Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Treatment, 2017–2031
        13.2.1. Subcutaneous Immunotherapy (SCIT)
        13.2.2. Sublingual Immunotherapy (SLIT)
    13.3. Market Value Forecast, by Allergy Type, 2017–2031
        13.3.1. Allergic Rhinitis
        13.3.2. Asthma
        13.3.3. Food Allergy
        13.3.4. Venom Allergy
        13.3.5. Others
    13.4. Market Value Forecast, by Distribution Channel, 2017–2031
        13.4.1. Hospital Pharmacies
        13.4.2. Retail Pharmacies & Drug Stores
        13.4.3. Online Pharmacies
    13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        13.5.1. Brazil
        13.5.2. Mexico
        13.5.3. Rest of Latin America
    13.6. Market Attractiveness Analysis
        13.6.1. By Treatment
        13.6.2. By Allergy Type
        13.6.3. By Distribution Channel
        13.6.4. By Country/Sub-region
14. Middle East & Africa Allergy Immunotherapy Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast, by Treatment, 2017–2031
        14.2.1. Subcutaneous Immunotherapy (SCIT)
        14.2.2. Sublingual Immunotherapy (SLIT)
    14.3. Market Value Forecast, by Allergy Type, 2017–2031
        14.3.1. Allergic Rhinitis
        14.3.2. Asthma
        14.3.3. Food Allergy
        14.3.4. Venom Allergy
        14.3.5. Others
    14.4. Market Value Forecast, by Distribution Channel, 2017–2031
        14.4.1. Hospital Pharmacies
        14.4.2. Retail Pharmacies & Drug Stores
        14.4.3. Online Pharmacies
    14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        14.5.1. GCC Countries
        14.5.2. South Africa
        14.5.3. Rest of Middle East & Africa
    14.6. Market Attractiveness Analysis
        14.6.1. By Treatment
        14.6.2. By Allergy Type
15. Competition Landscape
    15.1. Market Player – Competition Matrix (By Tier and Size of Companies)
    15.2. Market Share Analysis, by Company (2021)
    15.3. Company Profiles
        15.3.1. ALK-Abello A/S
            15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.1.2. Treatment Portfolio
            15.3.1.3. Financial Overview
            15.3.1.4. SWOT Analysis
            15.3.1.5. Strategic Overview
        15.3.2. Allergy Therapeutics
            15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.2.2. Treatment Portfolio
            15.3.2.3. Financial Overview
            15.3.2.4. SWOT Analysis
            15.3.2.5. Strategic Overview
        15.3.3. Stallergenes Greer
            15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.3.2. Treatment Portfolio
            15.3.3.3. Financial Overview
            15.3.3.4. SWOT Analysis
            15.3.3.5. Strategic Overview
        15.3.4. HAL Allergy Group
            15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.4.2. Treatment Portfolio
            15.3.4.3. Financial Overview
            15.3.4.4. SWOT Analysis
            15.3.4.5. Strategic Overview
        15.3.5. DBV Technologies
            15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.5.2. Treatment Portfolio
            15.3.5.3. Financial Overview
            15.3.5.4. SWOT Analysis
            15.3.5.5. Strategic Overview
        15.3.6. Merck KGaA
            15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.6.2. Treatment Portfolio
            15.3.6.3. Financial Overview
            15.3.6.4. SWOT Analysis
            15.3.6.5. Strategic Overview
        15.3.7. Aimmune Therapeutics
            15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.7.2. Treatment Portfolio
            15.3.7.3. Financial Overview
            15.3.7.4. SWOT Analysis
            15.3.7.5. Strategic Overview
        15.3.8. Carcassia
            15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.8.2. Treatment Portfolio
            15.3.8.3. Financial Overview
            15.3.8.4. SWOT Analysis
            15.3.8.5. Strategic Overview
        15.3.9. Anergis
            15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.9.2. Treatment Portfolio
            15.3.9.3. Financial Overview
            15.3.9.4. SWOT Analysis
            15.3.9.5. Strategic Overview
        15.3.10. Biomay AG
            15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.10.2. Treatment Portfolio
            15.3.10.3. Financial Overview
            15.3.10.4. SWOT Analysis
            15.3.10.5. Strategic Overview



List of Figures

List of Tables

Table 01: Global Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Treatment, 2017–2031

Table 01: Global Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Allergy Type, 2017–2031

Table 02: Global Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 04: Global Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 05: North America Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 06: North America Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Treatment, 2017–2031

Table 07: North America Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Allergy Type, 2017–2031

Table 08: North America Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 09: Europe Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 10: Europe Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Treatment, 2017–2031

Table 11: Europe Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 12: Europe Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Allergy Type, 2017–2031

Table 13: Asia Pacific Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Asia Pacific Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Treatment, 2017–2031

Table 15: Asia Pacific Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Allergy Type, 2017–2031

Table 16: Asia Pacific Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 17: Latin America Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 18: Latin America Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Treatment, 2017–2031

Table 19: Latin America Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Allergy Type, 2017–2031

Table 20: Latin America Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 21: Middle East & Africa Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 22: Middle East & Africa Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Treatment, 2017–2031

Table 23: Middle East & Africa Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Allergy Type, 2017–2031

Table 24: Middle East & Africa Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

List of Tables

List of Figures

Figure 01: Global Allergy Immunotherapy Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global Allergy Immunotherapy Market Value Share, by Treatment, 2022

Figure 03: Global Allergy Immunotherapy Market Value Share, by Distribution Channel, 2022

Figure 04: Global Allergy Immunotherapy Market Value Share, by Region, 2022

Figure 05: Global Allergy Immunotherapy Market Value Share Analysis, by Treatment, 2022 and 2031

Figure 06: Global Allergy Immunotherapy Market Attractiveness Analysis, by Treatment, 2023–2031

Figure 07: Global Allergy Immunotherapy Market Revenue (US$ Mn), by Silicone, 2017–2031

Figure 08: Global Allergy Immunotherapy Market Revenue (US$ Mn), by Polyolefins, 2017–2031

Figure 9: Global Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2022 and 2031

Figure 10: Global Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2023–2031

Figure 11: Global Allergy Immunotherapy Market Revenue (US$ Mn), by Allergic Rhinitis, 2017–2031

Figure 12: Global Allergy Immunotherapy Market Revenue (US$ Mn), Asthma, 2017–2031

Figure 13: Global Allergy Immunotherapy Market Revenue (US$ Mn), by Food Allergy, 2017–2031

Figure 14: Global Allergy Immunotherapy Market Revenue (US$ Mn), by Venom Allergy, 2017–2031

Figure 15: Global Allergy Immunotherapy Market Revenue (US$ Mn), by Others, 2017–2031

Figure 16: Global Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2017–2031

Figure 17: Global Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2023–2031

Figure 18: Global Allergy Immunotherapy Market Revenue (US$ Mn), by Hospital Pharmacies, 2017–2031

Figure 19: Global Allergy Immunotherapy Market Revenue (US$ Mn), by Retail Pharmacies & Drug Stores, 2017–2031

Figure 20: Global Allergy Immunotherapy Market Revenue (US$ Mn), by Online Pharmacies, 2017–2031

Figure 21: Global Allergy Immunotherapy Market Value Share Analysis, by Region, 2022 and 2031

Figure 22: Global Allergy Immunotherapy Market Attractiveness Analysis, by Region, 2023–2031

Figure 23: North America Allergy Immunotherapy Market Value (US$ Mn) Forecast, 2017–2031

Figure 24: North America Allergy Immunotherapy Market Value Share Analysis, by Country, 2022 and 2031

Figure 25: North America Allergy Immunotherapy Market Attractiveness Analysis, by Country, 2023–2031

Figure 26: North America Allergy Immunotherapy Market Value Share Analysis, by Treatment, 2022 and 2031

Figure 27: North America Allergy Immunotherapy Market Attractiveness Analysis, by Treatment, 2023–2031

Figure 28: North America Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2022 and 2031

Figure 29: North America Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2023–2031

Figure 30: North America Allergy Immunotherapy Market Value Share Analysis (US$ Mn), by Distribution Channel, 2017–2031

Figure 31: North America Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2023–2031

Figure 32: Europe Allergy Immunotherapy Market Value (US$ Mn) Forecast, 2017–2031

Figure 33: Europe Allergy Immunotherapy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 34: Europe Allergy Immunotherapy Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 35: Europe Allergy Immunotherapy Market Value Share Analysis, by Treatment, 2022 and 2031

Figure 36: Europe Allergy Immunotherapy Market Attractiveness Analysis, by Treatment, 2023–2031

Figure 37: Europe Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2022 and 2031

Figure 38: Europe Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2023–2031

Figure 39: Europe Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2017–2031

Figure 40: Europe Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2023–2031

Figure 41: Asia Pacific Allergy Immunotherapy Market Value (US$ Mn) Forecast, 2017–2031

Figure 42: Asia Pacific Allergy Immunotherapy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 43: Asia Pacific Allergy Immunotherapy Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 44: Asia Pacific Allergy Immunotherapy Market Value Share Analysis, by Treatment, 2022 and 2031

Figure 45: Asia Pacific Allergy Immunotherapy Market Attractiveness Analysis, by Treatment, 2023–2031

Figure 46: Asia Pacific Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2022 and 2031

Figure 47: Asia Pacific Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2023–2031

Figure 48: Asia Pacific Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2017–2031

Figure 49: Asia Pacific Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2023–2031

Figure 50: Latin America Allergy Immunotherapy Market Value (US$ Mn) Forecast, 2017–2031

Figure 51: Latin America Allergy Immunotherapy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 52: Latin America Allergy Immunotherapy Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 53: Latin America Allergy Immunotherapy Market Value Share Analysis, by Treatment, 2022 and 2031

Figure 54: Latin America Allergy Immunotherapy Market Attractiveness Analysis, by Treatment, 2023–2031

Figure 55: Latin America Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2017–2031

Figure 55: Latin America Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2023–2031

Figure 54: Latin America Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2017–2031

Figure 55: Latin America Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2023–2031

Figure 56: Middle East & Africa Allergy Immunotherapy Market Value (US$ Mn) Forecast, 2017–2031

Figure 57: Middle East & Africa Allergy Immunotherapy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 58: Middle East & Africa Allergy Immunotherapy Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 59: Middle East & Africa Allergy Immunotherapy Market Value Share Analysis, by Treatment, 2022 and 2031

Figure 60: Middle East & Africa Allergy Immunotherapy Market Attractiveness Analysis, by Treatment, 2023–2031

Figure 61: Middle East & Africa Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2017–2031

Figure 62: Middle East & Africa Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2023–2031

Figure 63: Middle East & Africa Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2017–2031

Figure 64: Middle East & Africa Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2023–2031